1. Alausa, Abdullahi, Victor, Ugwu Chukwuebuka, Fadahunsi, Olumide Samuel, Ogundepo, Sunday, Adegbola, Peter Ifeoluwa. 2022. Checkpoints and immunity in cancers: Role of GNG12. In Pharmacological research, 180, 106242. doi:10.1016/j.phrs.2022.106242. https://pubmed.ncbi.nlm.nih.gov/35513227/
2. Yuan, Jinghong, Yuan, Zhao, Ye, Aifang, Li, Tao, Cheng, Xigao. 2021. Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma. In Frontiers in immunology, 12, 758845. doi:10.3389/fimmu.2021.758845. https://pubmed.ncbi.nlm.nih.gov/34691083/
3. Li, Juan, Jin, Can, Zou, Chuanxin, Jin, Xin, Fan, Ping. 2020. GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma. In FEBS open bio, 10, 278-287. doi:10.1002/2211-5463.12784. https://pubmed.ncbi.nlm.nih.gov/31898405/
4. Xiang, Zijin, Lv, Qiaoli, Chen, Xueru, Li, Dangchi, Peng, Xiangdong. . Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway. In Bioscience reports, 40, . doi:10.1042/BSR20201578. https://pubmed.ncbi.nlm.nih.gov/32735016/
5. Chen, Yung-Che, Hsiao, Chang-Chun, Chen, Ting-Wen, Wang, Ting-Ya, Lin, Meng-Chih. 2020. Whole Genome DNA Methylation Analysis of Active Pulmonary Tuberculosis Disease Identifies Novel Epigenotypes: PARP9/miR-505/RASGRP4/GNG12 Gene Methylation and Clinical Phenotypes. In International journal of molecular sciences, 21, . doi:10.3390/ijms21093180. https://pubmed.ncbi.nlm.nih.gov/32365959/